Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Thomas M. Heinze is active.

Publication


Featured researches published by Thomas M. Heinze.


Anaerobe | 2010

Sudan azo dyes and Para Red degradation by prevalent bacteria of the human gastrointestinal tract

Haiyan Xu; Thomas M. Heinze; Donald D. Paine; Carl E. Cerniglia; Huizhong Chen

Sudan azo dyes have genotoxic effects and ingestion of food products contaminated with Sudan I, II, III, IV, and Para Red could lead to exposure in the human gastrointestinal tract. In this study, we examined thirty-five prevalent species of human intestinal bacteria to evaluate their capacity to degrade Sudan dyes and Para Red. Among these tested bacterial strains, 23, 13, 33, 30, and 29 out of 35 species tested were able to reduce Sudan I, II, III, IV, and Para Red, respectively, to some extent. Bifidobacterium infantis, Clostridium indolis, Enterococcus faecalis, Lactobacillus rhamnosus, and Ruminococcus obeum were able to reduce completely all four tested Sudan dyes and Para Red. Escherichia coli and Peptostreptococcus magnus were the only two strains that were not able to reduce any of the tested Sudan dyes and Para Red to any significant extent. Metabolites of the reduction of the tested Sudan dyes and Para Red by E. faecalis were isolated and identified by HPLC and LC/ESI-MS analyses and compared with authentic standards. Thus it appears that the ability to reduce Sudan dyes and Para Red except Sudan II is common among bacteria in the human colon.


Applied and Environmental Microbiology | 2011

Modification of Norfloxacin by a Microbacterium sp. Strain Isolated from a Wastewater Treatment Plant

Dae-Wi Kim; Thomas M. Heinze; Bong-Soo Kim; Laura K. Schnackenberg; Kellie A. Woodling; John B. Sutherland

ABSTRACT Antimicrobial residues found in municipal wastewater may increase selective pressure on microorganisms for development of resistance, but studies with mixed microbial cultures derived from wastewater have suggested that some bacteria are able to inactivate fluoroquinolones. Medium containing N-phenylpiperazine and inoculated with wastewater was used to enrich fluoroquinolone-modifying bacteria. One bacterial strain isolated from an enrichment culture was identified by 16S rRNA gene sequence analysis as a Microbacterium sp. similar to a plant growth-promoting bacterium, Microbacterium azadirachtae (99.70%), and a nematode pathogen, “M. nematophilum” (99.02%). During growth in medium with norfloxacin, this strain produced four metabolites, which were identified by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and nuclear magnetic resonance (NMR) analyses as 8-hydroxynorfloxacin, 6-defluoro-6-hydroxynorfloxacin, desethylene norfloxacin, and N-acetylnorfloxacin. The production of the first three metabolites was enhanced by ascorbic acid and nitrate, but it was inhibited by phosphate, amino acids, mannitol, formate, and thiourea. In contrast, N-acetylnorfloxacin was most abundant in cultures supplemented with amino acids. This is the first report of defluorination and hydroxylation of a fluoroquinolone by an isolated bacterial strain. The results suggest that some bacteria may degrade fluoroquinolones in wastewater to metabolites with less antibacterial activity that could be subject to further degradation by other microorganisms.


Veterinary Microbiology | 2009

Isolation of bacterial strains from bovine fecal microflora capable of degradation of ceftiofur.

Fatemeh Rafii; Anna J. Williams; Miseon Park; Lillie M. Sims; Thomas M. Heinze; Carl E. Cerniglia; John B. Sutherland

Ceftiofur, a third-generation cephalosporin used to treat bacterial infections in animals, is degraded in bovine feces but the specific bacteria involved are unknown. To find the bacteria involved in ceftiofur metabolism, the bovine fecal microflora was screened. Twenty-one nonidentical strains of bovine fecal bacteria were isolated on media containing 1-32 microg ml(-1) of ceftiofur. The cultures were incubated with 5 microg ml(-1) ceftiofur for different times, then centrifuged and analyzed by high-performance liquid chromatography. Three strains of Bacillus spp., two strains of Roseomonas spp., and one strain of Azospirillum sp. metabolized 5 microg ml(-1) ceftiofur in broth cultures in less than 24h; ten other strains of Roseomonas and one strain of Bacillus pumilus had metabolized it by 120 h. After the ceftiofur had been metabolized by these bacteria, the filter-sterilized supernatants of centrifuged cultures no longer inhibited the growth of a ceftiofur-sensitive strain of Kocuria rhizophila, which indicated that ceftiofur had been transformed to compounds without bactericidal activity. Each isolate was also found to be able to grow in the presence of other beta-lactams, and a nitrocefin assay showed beta-lactamase activity in the 17 strains that metabolized ceftiofur. The results show that some beta-lactamase-producing bacteria from the bovine fecal microflora are capable of transforming ceftiofur to metabolites lacking bactericidal activity.


Applied Microbiology and Biotechnology | 2005

Fungal biotransformation of benzo[f]quinoline, benzo[h]quinoline, and phenanthridine

John B. Sutherland; E. Lynn Cross; Thomas M. Heinze; James P. Freeman; Joanna D. Moody

Cultures of Umbelopsis ramanniana (=Mucor ramannianus) were grown in fluid Sabouraud medium for 3 days, dosed with 0.23 mM benzo[f]quinoline, benzo[h]quinoline, or phenanthridine (benzo[c]quinoline), and incubated for another 18 days. Cultures were extracted and metabolites (66–75% of the UV absorbance) were separated by high-performance liquid chromatography. They were identified by mass spectrometry and nuclear magnetic resonance spectroscopy. Benzo[f]quinoline was metabolized to benzo[f]quinoline trans-7,8-dihydrodiol, benzo[f]quinoline N-oxide, and 7-hydroxybenzo[f]quinoline, benzo[h]quinoline was metabolized to benzo[h]quinoline trans-5,6-dihydrodiol, benzo[h]quinoline trans-7,8-dihydrodiol, and 7-hydroxybenzo[h]quinoline, and phenanthridine was metabolized to phenanthridine N-oxide and phenanthridin-6(5H)-one. At least one of the metabolites produced from each compound was mutagenic and could not be considered detoxified.


Journal of Bioscience and Bioengineering | 2011

Biotransformation of quinazoline and phthalazine by Aspergillus niger

John B. Sutherland; Thomas M. Heinze; Laura K. Schnackenberg; James P. Freeman; Anna J. Williams

Cultures of Aspergillus niger NRRL-599 in fluid Sabouraud medium were grown with quinazoline and phthalazine for 7 days. Metabolites were purified by high-performance liquid chromatography and identified by mass spectrometry and proton nuclear magnetic resonance spectroscopy. Quinazoline was oxidized to 4-quinazolinone and 2,4-quinazolinedione, and phthalazine was oxidized to 1-phthalazinone.


Biocatalysis and Biotransformation | 2001

Fungal transformation of the tricyclic antidepressant amoxapine: identification of n-carbomethoxy compounds formed as artifacts by phosgene in chloroform used for the extraction of metabolites

Joanna D. Moody; Thomas M. Heinze; Carl E. Cerniglia

The biotransformation of the antidepressant drug amoxapine by Cunninghamella elegans formed three metabolites, 7-hydroxyamoxapine, N-formyl-7-hydroxyamoxapine, and N-formylamoxapine; two other compounds were only present when chloroform was used in the extraction process. All five of the compounds were separated by reversed-phase HPLC, then analyzed by 1H NMR and mass spectrometry, and by 13C NMR when sample quantities permitted. The artifacts were identified as N-carbomethoxy-7-hydroxyamoxapine and N-carbomethoxyamoxapine. Phosgene is a decomposition product of chloroform that can form carbomethoxy compounds at the secondary nitrogen of a piperazine ring in an alcoholic solution. Since N-carbomethoxy compounds were not observed when ethyl acetate was used for extraction of the culture medium, they were considered artifacts and not metabolites. These findings suggest that chloroform should be tested for the formation of phosgene before using it to extract any compound with a piperazine ring or any other amine-containing structure.


International Journal of Pharmaceutics | 2004

A kinetic study on the degradation of erythromycin A in aqueous solution

Yong-Hak Kim; Thomas M. Heinze; Richard D. Beger; Jairaj V. Pothuluri; Carl E. Cerniglia


Journal of Industrial Microbiology & Biotechnology | 2009

Decolorization of water and oil-soluble azo dyes by Lactobacillus acidophilus and Lactobacillus fermentum

Huizhong Chen; Haiyan Xu; Thomas M. Heinze; Carl E. Cerniglia


Fems Microbiology Letters | 1997

Evidence for the role of 2‐hydroxychromene‐2‐carboxylate isomerase in the degradation of anthracene by Sphingomonas yanoikuyae B1

Eungbin Kim; Gerben J. Zylstra; James P. Freeman; Thomas M. Heinze; Joanna Deck; Carl E. Cerniglia


Applied and Environmental Microbiology | 1996

Fungal biotransformation of the antihistamine azatadine by Cunninghamella elegans.

Donglu Zhang; E B Hansen; Joanna Deck; Thomas M. Heinze; John B. Sutherland; Carl E. Cerniglia

Collaboration


Dive into the Thomas M. Heinze's collaboration.

Top Co-Authors

Avatar

Carl E. Cerniglia

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

John B. Sutherland

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

James P. Freeman

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

Anna J. Williams

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

Fatemeh Rafii

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

Haiyan Xu

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

Huizhong Chen

National Center for Toxicological Research

View shared research outputs
Top Co-Authors

Avatar

Joanna D. Moody

National Center for Toxicological Research

View shared research outputs
Top Co-Authors

Avatar

Joanna Deck

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

Laura K. Schnackenberg

National Center for Toxicological Research

View shared research outputs
Researchain Logo
Decentralizing Knowledge